Susan S. Jick, DSc

Professor, Epidemiology
Susan Jick
Talbot – T518E
View full profile at BUMC


Dr. Susan Jick has been in the field of pharmacoepidemiology for over 25 years working with the Boston Collaborative Drug Surveillance Program where she has conducted research in many areas of drug safety. She has been involved with the use and development of large automated databases including the General Practice Research Database which has become a major resource for conducting drug safety studies and has changed the way these studies are being conducted today. Her research activities range from the safety of drugs such as oral contraceptives in relation to venous thrombosis, hormone replacement therapy in relation to cancers, antibiotics in relation to various serious health outcomes, and statins in relation to autoimmune diseases and diabetes, to safety of drug use in the first trimester of pregnancy and use of folic acid to prevent neural tube defects. Dr Jick helps to run a workshop on methods in conducting drug safety studies that is held each year, she teaches the drug epidemiology class at BUSPH and she serves as an advisor to doctoral students in epidemiology.


  • Carleton College, BA
  • Boston University, MPH
  • Boston University, DSc

Classes Taught

  • SPHEP748


  • Published on 10/1/2014

    Li L, Roddam A, Ferguson S, Feudjo-Tepie M, Taylor A, Jick S. Switch patterns of osteoporosis medication and its impact on persistence among postmenopausal women in the UK General Practice Research Database. Menopause. 2014 Oct; 21(10):1106-13.

    Read at: PubMed
  • Published on 9/7/2014

    Ishiguro C, Wang X, Li L, Jick S. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD. Pharmacoepidemiol Drug Saf. 2014 Nov; 23(11):1168-75.

    Read at: PubMed
  • Published on 9/2/2014

    Wilson AB, Neogi T, Prout M, Jick S. Relative risk of myelodysplastic syndromes in patients with autoimmune disorders in the General Practice Research Database. Cancer Epidemiol. 2014 Oct; 38(5):544-9.

    Read at: PubMed
  • Published on 9/1/2014

    Li L, Setoguchi S, Jick S. Validity of non-fatal idiopathic serious ventricular arrhythmia in UK-based Clinical Practice Research Datalink. Pharmacoepidemiol Drug Saf. 2014 Sep; 23(9):999-1001.

    Read at: PubMed
  • Published on 8/5/2014

    Hagberg KW, McGlynn KA, Sahasrabuddhe VV, Jick S. Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes. Br J Cancer. 2014 Oct 28; 111(9):1710-7.

    Read at: PubMed
  • Published on 8/1/2014

    Jick SS, Li L, Falcone GJ, Vassilev ZP, Wallander MA. Erratum to: Mortality of patients with multiple sclerosis: a cohort study in UK primary care. J Neurol. 2014 Aug; 261(8):1518-21.

    Read at: PubMed
  • Published on 7/22/2014

    Becker C, Jick SS, Meier CR, Bodmer M. Metformin and the risk of head and neck cancer: a case-control analysis. Diabetes Obes Metab. 2014 Nov; 16(11):1148-54.

    Read at: PubMed
  • Published on 7/6/2014

    Spoendlin J, Voegel JJ, Jick SS, Meier CR. Antihypertensive drugs and the risk of incident rosacea. Br J Dermatol. 2014 Jul; 171(1):130-6.

    Read at: PubMed
  • Published on 7/1/2014

    Mulder B, Schuiling-Veninga CC, Bos HJ, De Vries TW, Jick SS, Hak E. Response to the comment on: Prenatal exposure to acid-suppressive drugs and the risk of allergic disease in the offspring: a cohort study. Clin Exp Allergy. 2014 Jul; 44(7):1005.

    Read at: PubMed
  • Published on 6/19/2014

    Oleske DM, Bonafede MM, Jick S, Ji M, Hall JA. Electronic health databases for epidemiological research on joint replacements: considerations when making cross-national comparisons. Ann Epidemiol. 2014 Sep; 24(9):660-5.

    Read at: PubMed

View 181 more publications:View full profile at BUMC